Century Therapeutics(IPSC)
Focus: Century Therapeutics is a public biotech company headquartered in Philadelphia specializing in induced pluripotent stem cell (iPSC) therapy platforms for cell therapy applications. The company is in early-stage clinical development with a heavily R&D-focused business model.
Profile data last refreshed 3m ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
3-2 this month
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Should You Work at Century Therapeutics?
AI assessmentCentury Therapeutics offers exposure to cutting-edge iPSC platform science and early clinical catalysts, but extreme cash burn, minimal hiring velocity, and product portfolio ambiguity present material career risk for job seekers seeking stability.
Why Work Here
- Pioneering iPSC platform technology with differentiated cell therapy approach in a high-growth therapeutic area
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$7M
Key Products
Post-LOE
Legacy generic products in post-LOE status; minimal revenue contribution and strategic relevance to iPSC platform thesis.
Products & Portfolio (1)
Help build intelligence for Century Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.